Institut Gustave Roussy

USPTO Trademark & Patent Filings

Trademark applications and grants for Institut Gustave Roussy. Institut Gustave Roussy has 4 trademark applications. The latest application filed is for "IMMUNORAD"

Company Profile

INSTITUT GUSTAVE-ROUSSY
roussy gustave institut
Institut Gustave-Roussy - Villejuif FR
INSTITUT GUSTAVE ROUSSY - Vilejuif FR
INSTITUT GUSTAVE ROUSSY - VILLEJUIF FR
INSTITUT GUSTAVE ROUSSY - Villejuif N/A FR
INSTITUT GUSTAVE-ROUSSY - Villejuif N/A FR

Trademarks Patents

Patent Applications

Patent Application	Date
P21 Expressing Monocytes for Cancer Cell Therapy 20220257709 - 17/626360 PERFETTINI; Jean-Luc ; et al.	2022-08-18
MICROBIOTA COMPOSITION, AS A MARKER OF RESPONSIVENESS TO ANTI-PD1/PD-L1/PD-L2 20220056532 - 17/279565 ZITVOGEL; Laurence ; et al.	2022-02-24
MADRASIN-DERIVATIVE COMPOUNDS, COMPOSITION AND USES THEREOF FOR TREATING CANCER 20220047597 - 17/293506 APCHER; SEBASTIEN ; et al.	2022-02-17
Identification of a JAK2 Mutation in Polycythemia Vera 20220042016 - 17/488839 VAINCHENKER; William ; et al.	2022-02-10
ANTI-NEUROPILIN-1 AND ANTI-PROGRAMMED CELL DEATH-1 COMBINATION THERAPY FOR TREATING CANCER 20220023342 - 17/297052 MAMI-CHOUAIB; FATHIA ; et al.	2022-01-27
Cytokine derived treatment with reduced vascular leak syndrome 11,401,312 - 14/785,536 Bechard , et al. August 2, 2	2022-08-02
Microbiota composition, as a marker of responsiveness to chemotherapy, and use of microbial modulators (pre-, pro- or synbiotics) for improving the efficacy of a cancer treatment 11,344,586 - 16/854,117 Zitvogel , et al. May 31, 2	2022-05-31
5-hydroxytryptamine 1B receptor-stimulating agent for use as a promoter of satellite cells self-renewal and/or differentiation 11,344,515 - 16/669,626 Chretien , et al. May 31, 2	2022-05-31
Microbiota composition, as a marker of responsiveness to chemotherapy, and use of microbial modulators (pre-, pro- or synbiotics) for improving the efficacy of a cancer treatment 11,344,586 - 16/854,117 Zitvogel , et al. May 31, 2	2022-05-31
Method for assessing the response to PD-1/PDL-1 targeting drugs 11,293,066 - 16/631,848 Chouaib , et al. April 5, 2	2022-04-05

Patent Grants & Applications

Trademark Applications

Mark Image Registration \| Serial	Trademark Application Date
"IMMUNORAD" 5917326 79253804	IMMUNORAD 2018-12-19
"ENTESCENCE" 4741275 79146442	ENTESCENCE 2014-02-28
"GUSTAVE ROUSSY" 4586445 79133836	GUSTAVE ROUSSY 2013-05-27
"GUSTAVE ROUSSY" 4570312 79124800	GUSTAVE ROUSSY 2012-12-03

Company Registrations

NCAGE Code	FAZU3	INSTITUT GUSTAVE ROUSSY
CAGE Code	FAZU3	INSTITUT GUSTAVE ROUSSY

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.